Akèy › Skleroz an milti pwogresif kwonik › Kansas › Kansas City
Etid klinik pou Skleroz an milti pwogresif kwonik nan Kansas City, KS
3 etid pou Skleroz an milti pwogresif kwonik ap chèche patisipan nan sit nan ak bò kote Kansas City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Ap rekriteFaz 3
- University of Kansas Medical Center, Kansas City
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
Ap rekriteFaz 1/2
- University of Kansas Medical Center, Kansas City
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Ap rekriteFaz 3
- University of Kansas Hospital, Kansas City
Etid Skleroz an milti pwogresif kwonik nan lòt vil
- Chicago, IL4 etid
- St. Louis, MO4 etid
- Memphis, TN4 etid
- Orlando, FL4 etid
- Columbus, OH3 etid
- Tampa, FL3 etid
- Burbank, CA3 etid
- Greenville, SC3 etid
- Scottsdale, AZ3 etid
Lòt etid nan Kansas City
- Maladi kadyovaskilè14 etid
- Maladi poumon entèstisyèl13 etid
- Ensifizyans kadyak13 etid
- Obèsite13 etid
- Fibroz sistik13 etid
- Kansè vejik12 etid
- Kansè pwostat12 etid
- Kansè nan tete12 etid
- Kansè Poumon ki pa ti selil11 etid
- Leksemi mieloïd egi11 etid
- Kansè poumon11 etid
- BPCO9 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.